From randomized trials to registry studies: translating data into clinical information
Authors:
- 5 August 2008
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 5 (10) , 613-620
Abstract
All clinicians face the challenge of practicing evidence-based medicine and are confronted with data from a variety of studies, ranging from prospective randomized and registry studies to retrospective analyses. Unfortunately, the data frequently provide conflicting recommendations. How then should one interpret the information so that study findings can be applied directly in patient care? To evaluate the relevance of the abundance of studies published and how they apply to an individual patient, physicians must understand subtle nuances of study design and their effect on the interpretation of the results. In this Review, we examine the strengths and weaknesses of different study designs with the aim of providing the reader with a greater understanding how best to apply study results in the clinical setting.Keywords
This publication has 24 references indexed in Scilit:
- External Validity of Clinical Trials in Acute Myocardial InfarctionArchives of internal medicine (1960), 2007
- Clinical Judgment and Treatment Options in Stable Multivessel Coronary Artery DiseaseJACC, 2006
- Use and Misuse of Surrogate Outcomes in Arrhythmia TrialsCirculation, 2006
- One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A meta-analysis of individual patient data from randomized clinical trialsThe Journal of Thoracic and Cardiovascular Surgery, 2005
- One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS StentCirculation, 2004
- Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial InfarctionCirculation, 2003
- HOW TO REVIEW A PAPERAdvances in Physiology Education, 2003
- The Cardiac Arrhythmia Suppression TrialNew England Journal of Medicine, 1989
- RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2The Lancet, 1988
- Patients with malignant or potentially malignant ventricular arrhythmias: Opportunities and limitations of drug therapy in prevention of sudden deathJACC, 1985